Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 12:52 PM UTC
| NCT Number | NCT06216301 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 734 participants |
| Active Locations | 37 sites in the US |
| Sponsor | NovoCure GmbH |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of August 31, 2026: Clinical trial NCT06216301 is currently recruiting participants. This phase3 study for lung cancer is actively seeking new participants at 37 locations across the United States. The study is sponsored by NovoCure GmbH. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06216301 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 37 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06216301 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.